WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on immune-suppressing drugs to prevent organ rejection developed a mutated version of SARS-CoV-2 resistantContinue Reading
TUESDAY, Sept. 27, 2022 (HealthDay News) — Children who fall ill with COVID-19 may have a slightly increased risk of developing type 1 diabetes, a new study suggests. Researchers found that of more than 285,000 children with COVID, 0.04% were diagnosed with type 1 diabetes over the next six months.Continue Reading
SUNDAY, Sept. 25, 2022 (HealthDay News) — Although wearing reusable contact lenses is generally safe, it can be associated with a greater risk of a rare eye infection, new British research shows. In the study, people who wore reusable contact lenses were nearly four times more likely to develop theContinue Reading
THURSDAY, Sept. 22, 2022 (HealthDay News) – The fight against malaria could hinge on genetically engineered mosquitoes that have something called “gene drive.” Researchers from the Transmission: Zero team at Imperial College London report that they have engineered mosquitoes that slow the growth in their gut of the parasites thatContinue Reading
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — As people with HIV age, their odds for heart attack rise — and those with untreated hepatitis C have an even higher risk, a new study finds. “HIV and hepatitis C co-infection occurs because they share a transmission route — both viruses mayContinue Reading
TUESDAY, Sept. 20, 2022 (HealthDay News) — They look so cute, grazing quietly in your backyard. But the overpopulation of white-tailed deer across the Northeastern United States could help spread Lyme disease and another tick-borne illness, anaplasmosis, especially in suburban areas, a new study suggests. The research points out thatContinue Reading
FRIDAY, Sept. 16, 2022 (HealthDay News) — U.S. health officials are advising doctors not to overuse the only antiviral for monkeypox because there is a risk of the virus mutating and rendering the drug useless. TPOXX (tecovirimat) works by targeting just one protein found on monkeypox, as well as smallpoxContinue Reading
FRIDAY, Sept. 16, 2022 (HealthDay News) — In updated guidance issued Thursday, the World Health Organization now recommends against using the antibody drugs sotrovimab and casirivimab-imdevimab for patients with COVID-19. This recommendation replaces previous conditional recommendation for these antibody drugs. The change in guidance was based on emerging evidence thatContinue Reading
THURSDAY, Sept. 15, 2022 (HealthDay News) — Monkeypox cases continue to fall in the United States, but public health officials now are concerned that the virus is wending its way into communities of color. New case numbers are down by nearly half since early August, White House monkeypox response coordinatorContinue Reading
THURSDAY, Sept. 15, 2022 (HealthDay News) – The end of the COVID-19 pandemic is in sight, the leader of the World Health Organization declared Wednesday, with deaths at their lowest level worldwide since the new coronavirus first began to spread in March 2020. However, the death rate is relatively flatContinue Reading